Products & Services · Gross Profit
Tyvaso DPI — Gross Profit
United Therapeutics Tyvaso DPI — Gross Profit decreased by 11.7% to $247.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.9%, from $254.40M to $247.10M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2021
Last reportedQ1 2026
Rolls up toGross Profit
How to read this metric
Higher gross profit indicates strong pricing power and efficient production, while declining margins may suggest pricing pressure or rising input costs.
Detailed definition
Calculated as the total revenue from a specific product line minus the direct costs of sales associated with that produc...
Peer comparison
Standard gross margin analysis for specific drug products across the pharmaceutical sector.
Metric ID:
uthr_segment_tyvaso_dpi_gross_profitHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $52.80M | $98.00M | $160.60M | $174.00M | $182.90M | $194.20M | $220.70M | $235.50M | $234.80M | $254.40M | $266.70M | $280.90M | $279.90M | $247.10M |
| QoQ Change | — | — | — | — | +85.6% | +63.9% | +8.3% | +5.1% | +6.2% | +13.6% | +6.7% | -0.3% | +8.3% | +4.8% | +5.3% | -0.4% | -11.7% |
| YoY Change | — | — | — | — | — | — | +229.5% | — | +98.2% | +37.4% | +35.3% | +28.4% | +31.0% | +20.8% | +19.3% | +19.2% | -2.9% |
Range$0.00 – $280.90M
Avg YoY Growth+51.6%
Median YoY Growth+29.7%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is United Therapeutics's tyvaso dpi — gross profit?
- United Therapeutics (UTHR) reported tyvaso dpi — gross profit of $247.10M in Q1 2026.
- How has United Therapeutics's tyvaso dpi — gross profit changed year-over-year?
- United Therapeutics's tyvaso dpi — gross profit decreased by 2.9% year-over-year, from $254.40M to $247.10M.
- What does tyvaso dpi — gross profit mean?
- The profit remaining after subtracting direct production costs from product revenue.